Key result
Contour device achieves complete 6-month occlusion in ~44% of unruptured bifurcation aneurysms.
Answers are grounded in this paper and cite their sources.
BACKGROUND: The Contour is a novel intra-aneurysmal flow disrupting device to treat intracranial aneurysms. OBJECTIVE: To evaluate the safety and effectiveness of the Contour device for treatment of nonruptured intracranial bifurcation aneurysms through a prospective, multicenter, single-arm study. METHODS: Thirty-four patients were enrolled. Primary end points were successful occlusion at 6 mo for efficacy and any major stroke or nonaccidental death up to 30 d or major disabling stroke within 6 mo for safety. Secondary end points were occlusion at 12 mo, retreatment rate, procedure time, and procedure-related/device-related adverse events. Procedural and follow-up imaging was reviewed by an independent core laboratory. Adverse events were reviewed and adjudicated by a clinical events committee. RESULTS: In total, 32 of 34 aneurysms were successfully implanted and, 2 of 34 in the intention-to-treat (ITT) group did not receive the Contour and were excluded from follow-up after 30 d. In addition, 2 of 32 were lost to angiographic follow-up and regarded as treatment failure. The primary safety end point was met in 2 patients in the ITT group. In the perprotocol (PP) group, complete occlusion was seen in 14 of 32 (44%) at 6 mo and 22 of 32 (69%) at 12 mo. Adequate occlusion (Raymond-Roy [RR] 1 and 2) was reached in 84% at a last available follow-up. One patient from the ITT group and 1 from the PP group received additional treatment during follow-up. CONCLUSION: The Contour seems to be both safe and effective in the treatment of intracranial bifurcation aneurysms.
No takes yet. Share an insight, caveat, or question.
Liebig et al. (2021) studied Nonruptured intracranial bifurcation aneurysms (n=34). Contour Neurovascular System was evaluated on Successful occlusion at 6 months (efficacy) and any major stroke or nonaccidental death up to 30 days or major disabling stroke within 6 months (safety). The Contour device achieved complete occlusion at 6 months in 44% of per-protocol patients with nonruptured intracranial bifurcation aneurysms, with 2 of 34 patients experiencing a safety event.
Synapse has enriched 10 related papers. Consider them for comparative context: